[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
October 13, 2010

Advances in the Treatment of Opioid DependenceContinued Progress and Ongoing Challenges

Author Affiliations

Author Affiliation: Section of General Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

JAMA. 2010;304(14):1612-1614. doi:10.1001/jama.2010.1496

Illicit drug use is a major cause of morbidity and mortality worldwide. In the United States, the 2009 National Survey on Drug Use and Health documented that 8.7% of individuals older than 12 years reported past month illicit drug use.1 Illicit opioid use is an important contributor to health problems, including human immunodeficiency virus and hepatitis C infection and overdose-related deaths. While historically heroin has been most commonly abused, nonmedical use of prescription opioid pain relievers is now the dominant form of opioid abuse in the United States. In 2009, more than 5.3 million Americans reported past month prescription opioid abuse1 and the 2009 Monitoring the Future Study demonstrated that among 12th-graders, 9.7% reported abuse of hydrocodone and 4.9% reported abuse of oxycodone in the past year.2 Thus, illicit opioid use is a critical national health issue that requires creative approaches to prevention and treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×